rs10093032
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024915.4(GRHL2):c.1764-19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 1,471,252 control chromosomes in the GnomAD database, including 102,143 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11132 hom., cov: 31)
Exomes 𝑓: 0.37 ( 91011 hom. )
Consequence
GRHL2
NM_024915.4 intron
NM_024915.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.67
Publications
9 publications found
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2 Gene-Disease associations (from GenCC):
- autosomal dominant nonsyndromic hearing loss 28Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: STRONG Submitted by: ClinGen
- posterior polymorphous corneal dystrophyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
- nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fibrosis of extraocular musclesInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 8-101666570-C-T is Benign according to our data. Variant chr8-101666570-C-T is described in ClinVar as Benign. ClinVar VariationId is 261793.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.521 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRHL2 | NM_024915.4 | c.1764-19C>T | intron_variant | Intron 15 of 15 | ENST00000646743.1 | NP_079191.2 | ||
| GRHL2 | NM_001330593.2 | c.1716-19C>T | intron_variant | Intron 15 of 15 | NP_001317522.1 | |||
| GRHL2 | NM_001440448.1 | c.1716-19C>T | intron_variant | Intron 15 of 15 | NP_001427377.1 | |||
| GRHL2 | NM_001440447.1 | c.1763+2052C>T | intron_variant | Intron 15 of 15 | NP_001427376.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.378 AC: 57324AN: 151710Hom.: 11114 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
57324
AN:
151710
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.390 AC: 97367AN: 249724 AF XY: 0.392 show subpopulations
GnomAD2 exomes
AF:
AC:
97367
AN:
249724
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.366 AC: 482787AN: 1319424Hom.: 91011 Cov.: 20 AF XY: 0.370 AC XY: 245865AN XY: 664060 show subpopulations
GnomAD4 exome
AF:
AC:
482787
AN:
1319424
Hom.:
Cov.:
20
AF XY:
AC XY:
245865
AN XY:
664060
show subpopulations
African (AFR)
AF:
AC:
13175
AN:
30580
American (AMR)
AF:
AC:
20287
AN:
44422
Ashkenazi Jewish (ASJ)
AF:
AC:
9333
AN:
25292
East Asian (EAS)
AF:
AC:
13929
AN:
38972
South Asian (SAS)
AF:
AC:
44545
AN:
83386
European-Finnish (FIN)
AF:
AC:
17160
AN:
53336
Middle Eastern (MID)
AF:
AC:
2165
AN:
5532
European-Non Finnish (NFE)
AF:
AC:
341361
AN:
982168
Other (OTH)
AF:
AC:
20832
AN:
55736
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
16490
32980
49469
65959
82449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10630
21260
31890
42520
53150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.378 AC: 57386AN: 151828Hom.: 11132 Cov.: 31 AF XY: 0.380 AC XY: 28215AN XY: 74160 show subpopulations
GnomAD4 genome
AF:
AC:
57386
AN:
151828
Hom.:
Cov.:
31
AF XY:
AC XY:
28215
AN XY:
74160
show subpopulations
African (AFR)
AF:
AC:
17516
AN:
41354
American (AMR)
AF:
AC:
6335
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1350
AN:
3466
East Asian (EAS)
AF:
AC:
1795
AN:
5154
South Asian (SAS)
AF:
AC:
2584
AN:
4796
European-Finnish (FIN)
AF:
AC:
3318
AN:
10546
Middle Eastern (MID)
AF:
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23374
AN:
67924
Other (OTH)
AF:
AC:
795
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1787
3574
5360
7147
8934
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1790
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Corneal dystrophy, posterior polymorphous, 4 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant nonsyndromic hearing loss 28 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.